IL69095A - 9-(2-hydroxyethoxymethyl)-guanine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

9-(2-hydroxyethoxymethyl)-guanine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL69095A
IL69095A IL69095A IL6909583A IL69095A IL 69095 A IL69095 A IL 69095A IL 69095 A IL69095 A IL 69095A IL 6909583 A IL6909583 A IL 6909583A IL 69095 A IL69095 A IL 69095A
Authority
IL
Israel
Prior art keywords
sup
sub
hydroxyethoxymethyl
preparation
pharmaceutical compositions
Prior art date
Application number
IL69095A
Other languages
English (en)
Other versions
IL69095A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL69095A0 publication Critical patent/IL69095A0/xx
Publication of IL69095A publication Critical patent/IL69095A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL69095A 1982-06-29 1983-06-28 9-(2-hydroxyethoxymethyl)-guanine derivatives,their preparation and pharmaceutical compositions containing them IL69095A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8202626A NL8202626A (nl) 1982-06-29 1982-06-29 Derivaten van 9-(2-hydroxyethoxymethyl)guanine.

Publications (2)

Publication Number Publication Date
IL69095A0 IL69095A0 (en) 1983-10-31
IL69095A true IL69095A (en) 1985-11-29

Family

ID=19839947

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69095A IL69095A (en) 1982-06-29 1983-06-28 9-(2-hydroxyethoxymethyl)-guanine derivatives,their preparation and pharmaceutical compositions containing them

Country Status (13)

Country Link
US (1) US4548819A (fi)
EP (1) EP0099493B1 (fi)
JP (1) JPS5910587A (fi)
AT (1) ATE45580T1 (fi)
CA (1) CA1208637A (fi)
DE (1) DE3380410D1 (fi)
DK (1) DK159444C (fi)
FI (1) FI76087C (fi)
GB (1) GB2122618B (fi)
HU (1) HU189709B (fi)
IL (1) IL69095A (fi)
MY (1) MY102248A (fi)
NL (1) NL8202626A (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8513460D0 (en) * 1985-05-29 1985-07-03 Glaxo Group Ltd Chemical compounds
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
IT1223604B (it) * 1987-12-24 1990-09-29 Co Pharma Corp Srl Derivati purinici ad azione farmacologica
GB8800312D0 (en) * 1988-01-07 1988-02-10 Glaxo Group Ltd Process
DE68922903T2 (de) * 1988-12-19 1995-11-23 Wellcome Found Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
US5451799A (en) * 1992-12-28 1995-09-19 Matsushita Electric Industrial Co., Ltd. MOS transistor for protection against electrostatic discharge
DE69426880T2 (de) * 1993-06-10 2001-10-31 Rolabo S.L., Zaragoza Verfahren zur herstellung von aminosäureester von nukleosid analogen
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (fi) * 1993-11-18 1996-08-01 Ajinomoto Kk
EP0665229B1 (en) * 1994-02-01 1999-11-17 Ajinomoto Co., Inc. Process for the production of nucleic acid base derivatives
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
ES2180923T5 (es) * 1996-01-26 2005-10-16 F. Hoffmann-La Roche Ag Proceso para la preparacion de derivados de purina.
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
EP1569652A4 (en) 2001-12-14 2008-07-02 Pharmasset Inc NUCLEOSIDES N SP 4 / SP-ACYLCYTOSINES FOR THE TREATMENT OF VIRAL INFECTIONS
WO2005120577A2 (en) * 2004-06-09 2005-12-22 Ramot At Tel Aviv University Ltd. Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity
ATE546451T1 (de) 2005-05-25 2012-03-15 Lilly Co Eli Cyclopropancarbonsäureester von acyclovir
CN115745997A (zh) * 2022-11-30 2023-03-07 湖北省宏源药业科技股份有限公司 一种高纯度伐昔洛韦杂质h制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
AU515553B2 (en) * 1976-03-01 1981-04-09 The Wellcome Foundation Limited Purine derivatives
JPS52105195A (en) * 1976-03-01 1977-09-03 Wellcome Found Substituted purine

Also Published As

Publication number Publication date
JPS5910587A (ja) 1984-01-20
MY102248A (en) 1992-05-15
HU189709B (en) 1986-07-28
ATE45580T1 (de) 1989-09-15
GB2122618B (en) 1985-11-13
NL8202626A (nl) 1984-01-16
EP0099493B1 (en) 1989-08-16
DK297483A (da) 1983-12-30
IL69095A0 (en) 1983-10-31
DK297483D0 (da) 1983-06-28
CA1208637A (en) 1986-07-29
EP0099493A1 (en) 1984-02-01
JPH04990B2 (fi) 1992-01-09
FI76087C (fi) 1988-09-09
FI76087B (fi) 1988-05-31
US4548819A (en) 1985-10-22
DK159444C (da) 1991-03-18
FI832355A0 (fi) 1983-06-28
GB2122618A (en) 1984-01-18
GB8317504D0 (en) 1983-08-03
FI832355L (fi) 1983-12-30
DK159444B (da) 1990-10-15
DE3380410D1 (en) 1989-09-21

Similar Documents

Publication Publication Date Title
IL69095A (en) 9-(2-hydroxyethoxymethyl)-guanine derivatives,their preparation and pharmaceutical compositions containing them
HUT54144A (en) Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
RO91197B (ro) Procedeu pentru prepararea unor derivati de piridazinamina
HUT41809A (en) Process for preparing dideoxy-nucleosides and pharmaceutical compositions containing such compounds
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
ES8502117A1 (es) Un procedimiento para preparar derivados de purina.
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
ES8403494A1 (es) "un procedimiento para la preparacion de derivados de s-adenosilmetionina".
IL85945A0 (en) Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation
HUT51221A (en) Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients
ES8401944A1 (es) Procedimiento para la preparacion de derivados de acido salicilico.
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ES480113A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8800923A1 (es) Procedimiento para la obtencion de benzotiopiranonas
HUT50828A (en) Process for producing thienoimidazole derivatives and pharmaceutical compositions comprising same as active ingredient
IL93748A0 (en) Thienylacetic acid derivatives,their preparation and pharmaceutical compositions containing them
GEP19970666B (en) Process for the preparation of purine derivatives

Legal Events

Date Code Title Description
KB Patent renewed
KB20 Patent renewed for 20 years
EXP Patent expired